Table 2 Multivariate Cox regression analysis with survival gene signatures for the overall survival of DLBCL patients.

From: Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma

  

Training set (n = 414)

Test set (n = 179)

Entire set (n = 593)

Gene-expression variables

No. of genes

HR

95% CI

p-value

HR

95% CI

p-value

HR

95% CI

p-value

Favorable signature 1

86

0.66

0.53−0.81

<0.001

0.78

0.58−1.05

0.097

0.68

0.57−0.80

<0.001

Favorable signature 2

82

0.49

0.35−0.68

<0.001

0.62

0.36−1.06

0.078

0.53

0.40−0.70

<0.001

Unfavorable signature 1

92

1.83

1.37−2.43

<0.001

1.5

0.95−2.37

0.08

1.73

1.36−2.20

<0.001

Unfavorable signature 2

72

2.38

1.64–3.45

<0.001

2.26

1.32−3.86

0.003

2.26

1.68−3.03

<0.001

  1. Abbreviations: CI confidence interval, HR hazard ratio.
Back to article page